WeLeader Biomedical Co., Ltd. (TPEX:7713)
70.20
-0.80 (-1.13%)
At close: Mar 6, 2026
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.23 billion as of March 6, 2026. Its market cap has decreased by -1.07% in one year.
Market Cap
3.23B
Enterprise Value
3.79B
Revenue
1.11B
Ranking
n/a
PE Ratio
15.71
Stock Price
70.20
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.23B, a decrease of -5.87%. That is a compound annual growth rate of -2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.19B | -4.36% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medimaging Integrated Solution | 3.11B |
| A Plus Biotechnology | 2.79B |
| Applied BioCode | 2.52B |
| Bonraybio | 4.19B |
| Dynamic Medical Technologies | 2.33B |
| Wellell | 2.28B |
| Diamond Biotechnology | 2.03B |
| OK Biotech | 1.97B |